Pfizer shares expected to rise 15% with strong pipeline and 6.2% dividend yield, rated buy.
Pfizer is projected to increase 15.27% to $32.36 over the next 12 months, driven by a strong drug pipeline, raised revenue guidance, and a 6.19% dividend yield. Despite a recent $4.3 billion writedown and declines in COVID-related sales, Pfizer's new...
